Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 5Completed 4Terminated 3Withdrawn 1Recruiting 1Not yet recruiting 1Available 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Spinal Cord Compression 1Neoplasm Metastasis 1Hemorrhage 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Proton Pump Inhibitors × Clear all
NCT02167633 2021-03-11

Stereocord

Rigshospitalet, Denmark

Phase NA Terminated
10 enrolled

Neoplasm Metastasis, Spinal Cord Compression

NCT02150447 2018-04-04

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

National Cancer Center, Korea

Phase 3 Terminated
394 enrolled
Gastrointestinal

Hemorrhage, Stomach Neoplasms

NCT01129778 2017-06-06

Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus

Stanford University

Phase NA Terminated
27 enrolled 6 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡